Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Brachytherapy in the Palliation of Oesophageal Cancer: Effective but Impractical?

Sinha S, Varagunam M, Park MH, Maynard ND, Trudgill N, Crosby T, Cromwell DA.

Clin Oncol (R Coll Radiol). 2019 Jul;31(7):e87-e93. doi: 10.1016/j.clon.2019.03.045. Epub 2019 Apr 11.

PMID:
30982667
2.

Changes in volume, clinical practice and outcome after reorganisation of oesophago-gastric cancer care in England: A longitudinal observational study.

Varagunam M, Hardwick R, Riley S, Chadwick G, Cromwell DA, Groene O.

Eur J Surg Oncol. 2018 Apr;44(4):524-531. doi: 10.1016/j.ejso.2018.01.001. Epub 2018 Jan 11.

3.

Coding of Barrett's oesophagus with high-grade dysplasia in national administrative databases: a population-based cohort study.

Chadwick G, Varagunam M, Brand C, Riley SA, Maynard N, Crosby T, Michalowski J, Cromwell DA.

BMJ Open. 2017 Jun 9;7(6):e014281. doi: 10.1136/bmjopen-2016-014281.

4.

Population-based cohort study of the management and survival of patients with early-stage oesophageal adenocarcinoma in England.

Chadwick G, Riley S, Hardwick RH, Crosby T, Hoare J, Hanna G, Greenaway K, Varagunam M, Cromwell DA, Groene O.

Br J Surg. 2016 Apr;103(5):544-52. doi: 10.1002/bjs.10116. Epub 2016 Feb 11.

PMID:
26865114
5.

Relationship between patient-reported outcomes of elective surgery and hospital and consultant volume.

Varagunam M, Hutchings A, Black N.

Med Care. 2015 Apr;53(4):310-6. doi: 10.1097/MLR.0000000000000318.

PMID:
25654295
6.

Do patient-reported outcomes offer a more sensitive method for comparing the outcomes of consultants than mortality? A multilevel analysis of routine data.

Varagunam M, Hutchings A, Black N.

BMJ Qual Saf. 2015 Mar;24(3):195-202. doi: 10.1136/bmjqs-2014-003551. Epub 2014 Nov 3.

7.

Impact on hospital performance of introducing routine patient reported outcome measures in surgery.

Varagunam M, Hutchings A, Neuburger J, Black N.

J Health Serv Res Policy. 2014 Apr;19(2):77-84. doi: 10.1177/1355819613506187. Epub 2013 Sep 26.

PMID:
24072815
8.

Attrition revisited: adherence and retention in a web-based alcohol trial.

Murray E, White IR, Varagunam M, Godfrey C, Khadjesari Z, McCambridge J.

J Med Internet Res. 2013 Aug 30;15(8):e162. doi: 10.2196/jmir.2336.

9.

Influence of surgical rate on patients' reported clinical need and outcomes in English NHS.

Black N, Varagunam M, Hutchings A.

J Public Health (Oxf). 2014 Sep;36(3):497-503. doi: 10.1093/pubmed/fdt088. Epub 2013 Aug 28.

PMID:
23986543
10.

The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial.

de Brito-Ashurst I, Perry L, Sanders TA, Thomas JE, Dobbie H, Varagunam M, Yaqoob MM.

Heart. 2013 Sep;99(17):1256-60. doi: 10.1136/heartjnl-2013-303688. Epub 2013 Jun 13.

11.

Spiritual and religious interventions for well-being of adults in the terminal phase of disease.

Candy B, Jones L, Varagunam M, Speck P, Tookman A, King M.

Cochrane Database Syst Rev. 2012 May 16;(5):CD007544. doi: 10.1002/14651858.CD007544.pub2. Review.

PMID:
22592721
12.

Mild chronic kidney disease is an independent predictor of long-term mortality after emergency angiography and primary percutaneous intervention in patients with ST-elevation myocardial infarction.

Campbell NG, Varagunam M, Sawhney V, Ahuja KR, Salahuddin N, De Palma R, Rothman MT, Wragg A, Yaqoob MM, Knight CJ.

Heart. 2012 Jan;98(1):42-7. doi: 10.1136/heartjnl-2011-300024. Epub 2011 Aug 31.

PMID:
21880649
13.

Creatinine reduction ratio: a useful marker to identify medium and high-risk renal transplants.

Vilar E, Varagunam M, Yaqoob MM, Raftery M, Thuraisingham R.

Transplantation. 2010 Jan 15;89(1):97-103. doi: 10.1097/TP.0b013e3181be3dd1.

PMID:
20061925
14.

Bicarbonate supplementation slows progression of CKD and improves nutritional status.

de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM.

J Am Soc Nephrol. 2009 Sep;20(9):2075-84. doi: 10.1681/ASN.2008111205. Epub 2009 Jul 16.

15.

C3 polymorphisms and allograft outcome in renal transplantation.

Varagunam M, Yaqoob MM, Döhler B, Opelz G.

N Engl J Med. 2009 Feb 26;360(9):874-80. doi: 10.1056/NEJMoa0801861.

16.

Prevalence of cognitive impairment in patients attending pre-dialysis clinic.

Nulsen RS, Yaqoob MM, Mahon A, Stoby-Fields M, Kelly M, Varagunam M.

J Ren Care. 2008 Sep;34(3):121-6. doi: 10.1111/j.1755-6686.2008.00028.x.

PMID:
18786078
17.

Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?

Gupta A, Iveson V, Varagunam M, Bodger S, Sinnott P, Thuraisingham RC.

Transplantation. 2008 Apr 27;85(8):1200-4. doi: 10.1097/TP.0b013e31816b1c37.

PMID:
18431242
18.
19.

High pre-transplant soluble CD30 levels are predictive of the grade of rejection.

Rajakariar R, Jivanji N, Varagunam M, Rafiq M, Gupta A, Sheaff M, Sinnott P, Yaqoob MM.

Am J Transplant. 2005 Aug;5(8):1922-5.

20.

Pretransplantation levels of C-reactive protein predict all-cause and cardiovascular mortality, but not graft outcome, in kidney transplant recipients.

Varagunam M, Finney H, Trevitt R, Sharples E, McCloskey DJ, Sinnott PJ, Raftery MJ, Yaqoob MM.

Am J Kidney Dis. 2004 Mar;43(3):502-7.

PMID:
14981609
21.

Angiotensin-converting enzyme gene polymorphism and erythropoietin requirement.

Varagunam M, McCloskey DJ, Sinnott PJ, Raftery MJ, Yaqoob MM.

Perit Dial Int. 2003 Mar-Apr;23(2):111-5.

PMID:
12713075
22.

High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases.

Allen DA, Harwood S, Varagunam M, Raftery MJ, Yaqoob MM.

FASEB J. 2003 May;17(8):908-10. Epub 2003 Mar 28.

PMID:
12670885
23.

Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection.

Inward CD, Varagunam M, Adu D, Milford DV, Taylor CM.

Arch Dis Child. 1997 Aug;77(2):145-7.

24.

Anti-idiotypic activity against anti-myeloperoxidase antibodies in pooled human immunoglobulin.

Pall AA, Varagunam M, Adu D, Smith N, Richards NT, Taylor CM, Michael J.

Clin Exp Immunol. 1994 Feb;95(2):257-62.

25.

Pooled human IGG (PHIG) inhibits the binding of anti-myeloperoxidase antibodies to myeloperoxidase.

Pall AA, Varagunam M, Adu D, Smith N, Taylor CM, Michael J.

Adv Exp Med Biol. 1993;336:93-6.

PMID:
8296681
26.

Little evidence for anti-endothelial-cell antibodies in microscopic polyarteritis and Wegener's granulomatosis.

Varagunam M, Nwosu AC, Adu D, Garner C, Taylor CM, Michael J, Thompson RA.

Adv Exp Med Biol. 1993;336:419-22.

PMID:
8296647
27.

Endothelium, myeloperoxidase, anti-myeloperoxidase interaction in vasculitis.

Varagunam M, Adu D, Taylor CM, Michael J, Richards N, Neuberger J, Thompson RA.

Adv Exp Med Biol. 1993;336:129-32. No abstract available.

PMID:
8296601
28.

Little evidence for anti-endothelial cell antibodies in microscopic polyarteritis and Wegener's granulomatosis.

Varagunam M, Nwosu Z, Adu D, Garner C, Taylor CM, Michael J, Thompson RA.

Nephrol Dial Transplant. 1993;8(2):113-7.

PMID:
8096069

Supplemental Content

Loading ...
Support Center